(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlin...t is available in its catalogue: ,, Carbondiox..., http://www.reportlinker.com/p0164368/Carbondiox... ,, Incubators are the most critical equipment... and other applications for providing a controlled...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - O...ny") (TSX:ONC; NASDAQ: ONCY ) announced today that...offering, the underwriters have exercised in full ...ional 637,500 units. Each unit is comprised of one...arrant, and was sold at a price of US$3.00 per uni...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO Pte...el oral JAK2 inhibitor, SB1518, at The American So...tion in New Orleans. ,, Data will be presented ...lation trial of SB1518 detailing its safety, toler...) profile in dose levels ranging from 100 to 600 m...
(Date:12/2/2009)... The Scientist, a leading scientific...metrics’ Evolve “Intelligent” EM...dquo;Top 10 Innovations of 2009. , ...™ EMCCD camera from Photometrics ®, a ...and EMCCD cameras for the life sciences, was ranke...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3...,(Nasdaq: CRGN ), a clinical-stage biopharmaceuti...he appointment of Sean Cassidy, as Vice,President ...008. CuraGen,also announced today that David M. Wu...nuary 1, 2008 to pursue other opportunities, but w... an advisor to the Company., "We are pleased to w...
...ire-FirstCall/ - Athersys,Inc. (Nasdaq: ATHX ) an...SX:,ANP), announced today that Athersys has receiv...istration (FDA) to begin a Phase I clinical trial,...ment of acute myocardial,infarction (AMI). The com...ical study of a scalable, allogeneic cell product ...
...s, Inc. (Nasdaq: HGSI ) today announced that it w...sing and collaboration agreement with,Aegera Thera...d randomized,Phase 2 trial of HGS-ETR1 in combinat...m.com/cgi-bin/prnh/20010612/HGSLOGO ), This conf...d will be,held today, Thursday, December 20, 2007 ...
Other Biology Technology:CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 2CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 3CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 4Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 2Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 3Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 4Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 5Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction 6Human Genome Sciences to Sponsor Conference Call 2Mouse Anti-Human XPMC2H Polyclonal Antibody, Unconjugated from Novus Biologicals
BD Falcon cultivation flask from BD Biosciences - Discovery Labware
...sphere/Microarray Stabilizer is an aqueous solutio...r non-toxic chemicals in a PBS buffer (phosphate b...ns a combination of 0.02% methylisothiazolone and ...Coat Plus Stabilizer provides optimum performance ...
Mini Incubation Trays, 100 from Bio-Rad
Biology Products: